Home » Topics » BioWorld Science

BioWorld Science
RSS

NextCure initiates phase I/II trial of LAIR-2 biomimic NC-410

July 9, 2020

Angion begins phase II study in Brazil with ANG-3777 in patients with COVID-19 pneumonia

July 9, 2020

Eternity Bioscience patents hSTING receptor agonists

July 9, 2020

Bicyclerd identifies new IL-17 ligands

July 9, 2020

Esteve Pharmaceuticals presents new analgesics

July 9, 2020

Global Blood Therapeutics divulges SLC40A1 inhibitors

July 9, 2020

Insilico Medicine patents TLR7 and/or TLR8 antagonists

July 9, 2020

AIDS2020: Virtual -- Can state of the ART get to "see you next year"?

July 9, 2020

BOP1 as new prognostic biomarker in melanoma

July 9, 2020

Novel CLDN18.2-targeted 4-1BB bispecific antibody with potent antitumor activity

July 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...